Punnonen R, Vilska S, Grönroos M, Rauramo L
Maturitas. 1980 Dec;2(4):321-6. doi: 10.1016/0378-5122(80)90034-1.
Serum E1, E2 and E3 concentrations and E2/E1 ratio were measured after vaginal application of conjugated oestrogens, micronized 17 beta-oestradiol and oestriol. 2.4 mg of conjugated oestrogens caused a prompt elevation in the serum E1 concentration; the E2 level changed only slightly. After vaginal application of 2 mg micronized 17 beta-oestradiol the main serum oestrogen is E2 and the conversion of E2 to E1, as in oral administration, does not occur. A significant elevation in the serum E3 concentration was noted 2 h after the vaginal application of 0.5 mg oestriol. The E2/E1 ratio changed little after the application of conjugated oestrogens but increased considerably after the vaginal administration of 2 mg micronized 17 beta-oestradiol.
在阴道应用结合雌激素、微粒化17β-雌二醇和雌三醇后,测定血清E1、E2和E3浓度以及E2/E1比值。2.4mg结合雌激素导致血清E1浓度迅速升高;E2水平仅有轻微变化。阴道应用2mg微粒化17β-雌二醇后,血清主要雌激素为E2,且与口服给药不同,不会发生E2向E1的转化。阴道应用0.5mg雌三醇2小时后,血清E3浓度显著升高。应用结合雌激素后,E2/E1比值变化不大,但阴道给予2mg微粒化17β-雌二醇后,该比值显著升高。